2004 Clinical Trials Indica Topical 
The Cannigma
JANUARY 13, 2023
Edibles won’t produce the same experience, but topicals may be able to help, too. 4 A 2004 study found that the endocannabinoid anandamide can inhibit trigeminal neurons, which suggests a way in which endocannabinoids may be able to prevent migraines. Topical cannabis products can also be useful, but research and data is very limited.
Greencamp
AUGUST 16, 2018
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step. High in THC.
Expert insights. Personalized for you.
132 
Let's personalize your content